N@N

HOVNP, WBMD, PGTI, RPTP, SAIA, CPRX Are Seasonally Ripe To Go Down In the Next Five Weeks

September 16, 2016 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net is monitoring the Seasonality of Hovnanian Enterprises Inc. (NASDAQ:HOVNP), WebMD Health Corp (NASDAQ:WBMD), PGT Inc. (NASDAQ:PGTI), Raptor Pharmaceutical Corp. (NASDAQ:RPTP), Saia Inc. (NASDAQ:SAIA), Citigroup Cap VI 6 7/8 % Trust Pfd Secs 1999-15.3.29 Called For Red 14.10.04 At USD 25.00 A Sec (NYSE:CPRX) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. buyins.net is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:

The following stocks are expected to go Down:

  Symbol  Company                          Expected Return  Odds                 By The Following Date
  HOVNP   Hovnanian Enterprises Inc.       -11.20%          100.00% (11 of 11)   Thursday, September 29th 2016
  WBMD    WebMD Health Corp                -5.81%           90.00% (9 of 10)     Tuesday, September 27th 2016
  PGTI    PGT Inc.                         -8.24%           90.00% (9 of 10)     Thursday, September 22nd 2016
  RPTP    Raptor Pharmaceutical Corp.      -4.40%           88.24% (15 of 17)    Monday, September 19th 2016
  SAIA    Saia Inc.                        -7.06%           100.00% (13 of 13)   Thursday, September 22nd 2016
  CPRX    Citigroup Cap VI 6 7/8 % Trust Pfd Secs 1999-15.3.29 Called For Red 14.10.04 At USD 25.00 A Sec  -20.91%          88.89% (8 of 9)      Thursday, October 27th 2016

Hovnanian Enterprises Inc. (NASDAQ:HOVNP) - Hovnanian Enterprises, Inc. designs, constructs, markets, and sells residential homes in the United States. It constructs single-family detached homes, attached townhomes and condominiums, urban infill, and active lifestyle homes. The company markets its build homes for first-time buyers, first-time and second-time move-up buyers, luxury buyers, active lifestyle buyers, and empty nesters in 219 communities in 34 markets. It also provides financial services comprising originating mortgages from homebuyers and selling such mortgages in the secondary market, as well as offers title insurance services. The company was founded in 1959 and is headquartered in Red Bank, New Jersey..

WebMD Health Corp (NASDAQ:WBMD) - WebMD Health Corp. provides health information services to consumers, physicians and other healthcare professionals, employers, and health plans through its public and private online portals, mobile platforms, and health-focused publications in the United States. Its primary public portal is WebMD.com, which enables consumers to obtain information on health and wellness topics or on a particular disease or condition; assess personal health status; use online trackers, tools, and quizzes; locate physicians; receive periodic e-mailed newsletters and alerts on topics of individual interest; and participate in online communities with peers and experts. The company s public portal, Medscape.com also enables physicians and healthcare professionals to access clinical reference sources; stay abreast of the latest clinical information; learn about new treatment options; earn continuing medical education credit; and communicate with peers. It also offers private portals and related services under the WebMD Health Services brand. The company hosts its WebMD Health Services platform for private and public sector employers, and health plans and its cloud-based online services accessed by its employees and plan participants using a computer, a tablet, or a smartphone. In addition, it sells information products and services on a stand-alone basis. WebMD Health Corp. is headquartered in New York, New York..

PGT Inc. (NASDAQ:PGTI) - PGT, Inc. manufactures and supplies residential impact-resistant windows and doors in the Southeastern United States, the Gulf Coast, Coastal mid-Atlantic, the Caribbean, Central America, and Canada. The company offers heavy-duty aluminum or vinyl frames with laminated glass to provide protection from hurricane-force winds and wind-borne debris; and impact-resistant vinyl window and door products for the mid- to high-end of the replacement market, primarily for single and multi-family homes and low to mid-rise condominiums. It also provides architectural systems products that provide protection from hurricane-force winds and wind-borne debris for mid- and high-rise buildings; high-end aluminum impact-resistant windows and doors; and non-impact-resistant aluminum frame windows and doors. In addition, the company offers non-glass vertical and horizontal sliding panels for porch enclosures, such as vinyl-glazed, aluminum-framed products used for enclosing screened-in porches that provide protection from inclement weather; and commercial storefront window system and entry doors. PGT, Inc. markets its products under the WinGuard, Eze-Breeze, SpectraGuard, PremierVue, WinGuard Vinyl, EnergyVue, Estate Collection, Sentinel, Estate Entrances, Commercial Series, and Targa names, as well as PGT Architectural Systems and PGT Commercial Storefront System brand names. It serves residential new construction, and repair and remodeling end markets through window distributors, building supply distributors, window replacement dealers, and enclosure contractors. The company was formerly known as JLL Window Holdings, Inc. and changed its name to PGT, Inc. in February 2006. PGT, Inc. was founded in 1980 and is headquartered in North Venice, Florida..

Raptor Pharmaceutical Corp. (NASDAQ:RPTP) - Raptor Pharmaceutical Corp., a biopharmaceutical company, focuses on developing and commercializing transformative treatments for people affected by rare and debilitating diseases. The company offers PROCYSBI, a delayed-release capsule, which is used for the management of nephropathic cystinosis in adults, as well as in six years and older children in the United States, in the 28 member states of the European Union, Norway, Liechtenstein, and Iceland. It also provides QUINSAIR, a formulation of the antibiotic drug levofloxacin for the treatment of chronic pulmonary infections due to Pseudomonas aeruginosa in cystic fibrosis patients in Canada and Europe. The company s clinical development programs include RP103 that is used as a treatment for Huntington's disease; and RP103 as a treatment for mitochondrial disorders, including Leigh syndrome. Its preclinical product candidates include RP105 and RP106 for various rare diseases. Raptor Pharmaceuticals Corp. has a license agreement with University of California. The company was founded in 2005 and is headquartered in Novato, California..

Saia Inc. (NASDAQ:SAIA) - Saia, Inc., through its subsidiaries, operates as a transportation company in the United States. It provides regional and interregional less-than-truckload, truckload, guaranteed, expedited, and logistics services. The company offers solutions for shipments between 100 and 10,000 pounds. As of December 31, 2015, it had a network of 49 owned service facilities and 95 leased service facilities; and approximately 3,932 tractors and 12,371 trailers. The company as formerly known as SCS Transportation, Inc. Saia, Inc. was founded in 2000 and is headquartered in Johns Creek, Georgia..

Citigroup Cap VI 6 7/8 % Trust Pfd Secs 1999-15.3.29 Called For Red 14.10.04 At USD 25.00 A Sec (NYSE:CPRX) - Catalyst Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies for people with rare debilitating diseases. Its lead product candidate is Firdapse, a proprietary form of amifampridine phosphate, which completed Phase III clinical trial for the treatment of patients with Lambert-Eaton Myasthenic syndrome; and is in small blinded clinical trial to treat Congenital Myasthenic syndromes, as well as is in Phase II/III clinical trial for the treatment of MuSK-antibody positive myasthenia gravis. The company also develops CPP-115, a GABA aminotransferase inhibitor that is in Phase Ib clinical trial for the treatment of epilepsy and other neurological indications, such as complex partial seizures and Tourette s disorder; and CPP-109 to treat Tourette s disorder. It has a strategic collaboration with BioMarin Pharmaceutical Inc. for the development of Firdapse. The company was formerly known as Catalyst Pharmaceutical Partners, Inc. and changed its name to Catalyst Pharmaceuticals, Inc. in May 2015. Catalyst Pharmaceuticals, Inc. was founded in 2002 and is based in Coral Gables, Florida..

About BUYINS.NET

BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS Friction Factor - Market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements" Naked Shorts (RegSho) - Tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING Earnings - Predicts probability, price move and length of move before and after all US stock earnings reports Seasonality - Predicts probability, price move and length of move based on exact time of year for all US stocks Group Correlation - Tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups SqueezeTrigger - Massive database that tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock. Valuation - Tracks all known valuation models and applies them. GATS - Tracks and quantifies known trading strategies by backtesting, optimizing and running genetic algorithms and neural networks to ascertain best trading strategies. PatternScan - Automates tracking of every technical pattern and predicts next move in stocks. Insider - Tracks insiders trading records and determines trading performance. Trades by higher-level insiders are generally more predictive than trades by lower level insiders Events - Tracks patterns directly correlated to specific events.

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. [symbol] has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net